TCI Wealth Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
CCM
GCM
TCI Wealth Advisors's MYGN Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Myriad Genetics (MYGN) in Q2 2023, closing a stake of 95 shares — an estimated $2.21K sold.
TCI Wealth Advisors first reported a position in MYGN in Q3 2017 and held it in 23 quarters. The position peaked at $9K in Q1 2022. 188 funds tracked by Wall St. Rank hold MYGN as of Q2 2023.
- TCI Wealth Advisors reported no remaining Myriad Genetics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 95 Myriad Genetics shares in Q2 2023, an estimated $2.21K.
- TCI Wealth Advisors first reported a position in Myriad Genetics in Q3 2017 and held it in 23 quarters.
- TCI Wealth Advisors's Myriad Genetics position peaked at $9K in Q1 2022.
- 188 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.